company profile of Suzhou Lixin Pharmaceutical Co., Ltd，Contact Information for Suzhou Lixin Pharmaceutical Co., Ltd In Page 2

Categories

Contact Supplier

From:
To:
Suzhou Lixin Pharmaceutical Co., Ltd
Send a Copy to this Email
Message:
Upload Images / Files
- Supports jpg, jpeg, png,
gif, pdf, doc, docx,
xls, xlsx, txt, rar and zip
- Max upload 3 files;
Max total size: 3MB
(0/3)
Verification:

Previous page 1 2 3 Next page

Company Profile

Since its establishment in 2000, Lixin Pharmaceutical Co., Ltd. has adhered to the goal of serving the global regulatory pharmaceutical market. Through technological innovation and standardized management, the company is continually developing and producing high-quality APIs and intermediates to meet the human pursuit of high-quality drugs. Adhering to corporate culture of scientific, rigorous, and standardized, advocating the spirit of innovation, and focus on the development and application of safety, environmental-friendly, low consumption, and high-quality original process technologies, Lixin Pharmaceutical has gradually established the production lines in the fields of anti-tumor, cardiovascular, antiviral, and digestive systems. Lixin has over 30 international invention patents in China, the United States, Europe, and other regions, forming a company-own intellectual property system. Lixin has submitted 4 DMF of API to US FDA, and obtained 8 CEP, NMPA new drug certificates, and over 20 domestic GMP certificates. Meanwhile, more than 20 products are under development for both domestic and foreign market, which laying a solid foundation for the company's sustainable development. Lixin Pharmaceutical adheres to the implementation of a globally standardized GMP management system and continuously improves and pursues excellence. The company has a R&D center with a total area of over 3000 square meters. There are two GMP factories located in Suzhou city of Jiangsu province and Zibo city of Shandong province. Both factories have multiple GMP workshops and professional APIs production lines, equipped with advanced sewage treatment systems and other supporting facilities. The factories have passed multiple inspections by NMPA, US FDA, EDQM, and EMA, and will provide high-quality services to global pharmaceutical companies through a sustainable and healthy development philosophy.

more >

Our Company Our Business

Year of Establishment: 2000

Total Assets(USD): 500,000 to 99,999,999

Total Number of Staff: 500-1000

Main Competitive Advantages: Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service

Other Competitive Advantages: Professional:Professional and experienced regulations, patents and sales teams provide end customers with a full range of professional services. Factory:We will firmly control from the starting material to the final product, give full play to the advantages of the entire industry chain, and form advantages in terms of material cost and management cost through large-scale production. Technical:With many years of technology accumulation and continuous investment, it has a number of patented core technologies; a variety of research and development pipelines to promote product upgrades and process upgrades through continuous innovation. Dedicated:Dedicated production line of different types of products to ensure compliance and quality control, improve product competitiveness.

Patents and Copyrights: Dozens including international PCT patents. Patent authorization for inventions in the US, Europe and China. Obtained government awards and peer recognition.

Business Type: Manufacturer

R&D capacity: Own Brand

Annual Turnover(USD): 500,000 to 99,999,999

Main Sales Markets: North America,Western Europe,Eastern Europe,Asia

Patents and Copyrights: Dozens including international PCT patents. Patent authorization for inventions in the US, Europe and China. Obtained government awards and peer recognition.

Send Inquiry View More

Suzhou Lixin Pharmaceutical Co., Ltd
Contact Person : Yu Jun
Tel : Click to View
Fax : -512-88169811

Certificates/Standards View More

AFM

Capecitabine GMP

FDA-EIR

Indapamide

Pemetrexed Disodium

Capecitabine

Send your message to this supplier

From:
To:
Suzhou Lixin Pharmaceutical Co., Ltd
Send a Copy to this Email
Message:
Upload Images / Files
- Supports jpg, jpeg, png,
gif, pdf, doc, docx,
xls, xlsx, txt, rar and zip
- Max upload 3 files;
Max total size: 3MB
(0/3)

Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now
Verification: